The association of medical providers’ attitudes about naloxone and people with opioid use disorder and their self-reported “low-barrier” treatment practices

Opioid-involved overdose deaths continue to climb, in part because of suboptimal access to and retention on medications for opioid use disorder (MOUD), including buprenorphine. Low barrier buprenorphine treatment aims to reduce or eliminate the threshold for getting and staying on medication by prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Winograd, Rachel P., Coffey, Bridget, Nance, Melissa, Carpenter, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480593/
https://www.ncbi.nlm.nih.gov/pubmed/37680698
http://dx.doi.org/10.1016/j.abrep.2023.100514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480593/
https://www.ncbi.nlm.nih.gov/pubmed/37680698
http://dx.doi.org/10.1016/j.abrep.2023.100514

Ejemplares similares